Cetuximab-conjugated magneto-fluorescent silica nanoparticles for in vivo colon cancer targeting and imaging (Q39658043)

13 September 2017

title

Cetuximab-conjugated magneto-fluorescent silica nanoparticles for in vivo colon cancer targeting and imaging (English)

1 reference

13 September 2017

0 references

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20826046

9 July 2024

magnetism

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20826046

9 July 2024

4

Kwan Soo Hong

1 reference

13 September 2017

9

Gyu-Chul Yi

1 reference

13 September 2017

Young-Seok Cho

1

1 reference

13 September 2017

Tae-Jong Yoon

2

1 reference

13 September 2017

Eue-Soon Jang

3

1 reference

13 September 2017

Shin Young Lee

5

1 reference

13 September 2017

Ok Ran Kim

6

1 reference

13 September 2017

Cheongsoo Park

7

1 reference

13 September 2017

Yong-Jin Kim

8

1 reference

13 September 2017

Kiyuk Chang

10

1 reference

13 September 2017

language of work or name

English

0 references

publication date

9 September 2010

1 reference

full work available at URL

13 September 2017

https://api.elsevier.com/content/article/PII:S030438351000385X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.004

https://api.elsevier.com/content/article/PII:S030438351000385X?httpAccept=text/plain

9 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.004

9 July 2024

1 reference

13 September 2017

volume

299

1 reference

13 September 2017

issue

1

1 reference

13 September 2017

page(s)

63-71

1 reference

13 September 2017

cites work

Cancer statistics, 2008

1

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.004

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

9 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.004

Nanoshell magnetic resonance imaging contrast agents

9 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.004

Multifunctional nanoparticles possessing a "magnetic motor effect" for drug or gene delivery

9 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.004

Specific targeting, cell sorting, and bioimaging with smart magnetic silica core-shell nanomaterials

9 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.004

Molecular imaging in cancer

9 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.004

Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging.

9 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.004

Human transferrin receptor gene as a marker gene for MR imaging

9 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.004

Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery

9 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.004

Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems.

9 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.004

In vivo imaging of tumor response to therapy using a dual-modality imaging strategy

9 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.004

Biomimetic amplification of nanoparticle homing to tumors

9 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.004

EGF, TGF-alpha, and EGF-R in human colorectal adenocarcinoma.

9 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.004

Expression of the tyrosine kinase activity growth factor receptors (EGFR, ERB B2, ERB B3) in colorectal adenocarcinomas and adenomas

9 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.004

Epidermal growth factor receptor immunohistochemical reactivity in patients with American Joint Committee on Cancer Stage IV colon adenocarcinoma: implications for a standardized scoring system

9 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.004

Development of gelatin nanoparticles with biotinylated EGF conjugation for lung cancer targeting.

9 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.004

Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts

9 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.004

EGFR antagonists in cancer treatment

9 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.004

Fluorescent magnetic nanohybrids as multimodal imaging agents for human epithelial cancer detection.

9 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.004

Controlled targeting of liposomal doxorubicin via the folate receptor in vitro.

9 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.004

In vivo cancer targeting and imaging with semiconductor quantum dots

9 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.004

Intracellular Trafficking of Magnetic Nanoparticles to Design Multifunctional Biovesicles

9 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.004

Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes.

9 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.004

The cell penetrating peptides pVEC and W2-pVEC induce transformation of gel phase domains in phospholipid bilayers without affecting their integrity

9 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.004

Nuclear targeting of gold nanoparticles in cancer cells induces DNA damage, causing cytokinesis arrest and apoptosis

9 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.004

Intracellular localization and cytotoxicity of spherical mesoporous silica nano- and microparticles

9 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.004

In vivo study of biodistribution and urinary excretion of surface-modified silica nanoparticles

9 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.004

Fluorescent silica nanoparticles with efficient urinary excretion for nanomedicine

9 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.004

9 July 2024

Identifiers

1 reference

13 September 2017

1 reference